BBLG Q2 2024 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$809,665

Net Income

-$783,733

EPS (Diluted)

$-0.67

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$895,865

Free Cash Flow

-$895,865

Stock-Based Comp.

$17,443

Balance Sheet

Total Assets

$3M

Total Liabilities

$284,507

Stockholders' Equity

$3M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$809,665	-$3M	+73.4%
Net Income	-$783,733	-$2M	+55.7%